RPSA
BMY icon

Richard P. Slaughter Associates’s Bristol-Myers Squibb BMY Stock Holding History

Richard P. Slaughter Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,327
Closed -$325K – 118
2025
Q1 		$325K Sell
5,327
-29,570
-85% -$1.72M 0.08% 100
2024
Q4 		$1.97M Sell
34,897
-1,804
-5% -$101K 0.44% 58
2024
Q3 		$1.9M Buy
36,701
+2,137
+6% +$100K 0.44% 61
2024
Q2 		$1.44M Buy
34,564
+4,047
+13% +$181K 0.34% 81
2024
Q1 		$1.65M Buy
30,517
+1,102
+4% +$56.1K 0.4% 67
2023
Q4 		$1.51M Buy
29,415
+3,000
+11% +$157K 0.37% 80
2023
Q3 		$1.53M Buy
26,415
+4,375
+20% +$268K 0.41% 69
2023
Q2 		$1.41M Buy
22,040
+750
+4% +$50.3K 0.4% 73
2023
Q1 		$1.48M Buy
21,290
+1,695
+9% +$120K 0.48% 62
2022
Q4 		$1.41M Buy
19,595
+612
+3% +$46.1K 0.44% 69
2022
Q3 		$1.35M Buy
18,983
+16,363
+625% +$1.19M 0.56% 60
2022
Q2 		$201K Buy
+2,620
New +$200K 0.09% 121

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Richard P. Slaughter Associates's BMY Position: Q2 2025 in Review

Richard P. Slaughter Associates sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 5,327 shares — an estimated $325K sold.

Richard P. Slaughter Associates first reported a position in BMY in Q2 2022 and held it in 12 quarters. The position peaked at $1.97M in Q4 2024. 2,299 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Richard P. Slaughter Associates reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Richard P. Slaughter Associates sold 5,327 Bristol-Myers Squibb shares in Q2 2025, an estimated $325K.
  • Richard P. Slaughter Associates first reported a position in Bristol-Myers Squibb in Q2 2022 and held it in 12 quarters.
  • Richard P. Slaughter Associates's Bristol-Myers Squibb position peaked at $1.97M in Q4 2024.
  • 2,299 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Richard P. Slaughter Associates's 13F filing for Q2 2025, filed 8 Jul 2025.